Trends in the Notification Rates and Treatment Outcome of Tuberculosis in Shandong Province, China, 2005–2021

References

• Zhu W, Wang Y, Li T, Chen W, Wang W. Gap to end-TB targets in eastern China: a joinpoint analysis from population-based notification data in Zhejiang Province, China, 2005–2018. Inter J Infect Dis. 2021;104:407–414. doi:10.1016/j.ijid.2021.01.007
   PubMed Web of Science ®Google Scholar
• Wang W, Zhao Q, Yuan Z, et al. Tuberculosis-associated mortality in Shanghai, China: a longitudinal study. Bullet World Health Organ. 2015;93(12):826–833. doi:10.2471/BLT.15.154161
   PubMed Web of Science ®Google Scholar
• Liu Y, Zheng Y, Chen J, et al. Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study. Int J Tuberc Lung Dis. 2018;22(6):655–660. doi:10.5588/ijtld.17.0726
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report 2022; 2022 Available from: https://www.who.int/publications/i/item/9789240061729.Accessed. November 08,2023.
   Google Scholar
• World Health Organization. Global tuberculosis report 2023; 2023 Available from: https://www.who.int/publications/i/item/9789240083851. Accessed February 21, 2024.
   Google Scholar
• China Tuberculosis Control Collaboration. The effect of tuberculosis control in China. Lancet. 2004;364(9432):417–422
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-2
   PubMed Web of Science ®Google Scholar
• Wingfield T, Karmadwala F, MacPherson P, et al. Challenges and opportunities to end tuberculosis in the COVID-19 era. Lancet Respir Med. 2021;9(6):556–558. doi:10.1016/S2213-2600(21)00161-2
   PubMed Web of Science ®Google Scholar
• Surendra H, Elyazar IRF, Puspaningrum E, et al. Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide longitudinal analysis of programme data. Lancet Glob Health. 2023;11(9):e1412–e1421. doi:10.1016/S2214-109X(23)00312-1
   PubMed Web of Science ®Google Scholar
• Muñiz-Salazar R, Le T, Cuevas-Mota J, et al. Impact of COVID-19 on tuberculosis detection and treatment in Baja California, México. Front Public Health. 202210 ;10.
   Web of Science ®Google Scholar
• Masina HV, Lin IF, Chien L-Y. The impact of the COVID-19 pandemic on tuberculosis case notification and treatment outcomes in Eswatini. Int J Public Health. 2022;67:1605225.
   PubMed Web of Science ®Google Scholar
• Yakupogullari Y, Ermis H, Kazgan Z, et al. Diagnostic and treatment outcomes of patients with pulmonary tuberculosis in the first year of COVID-19 pandemic. East Mediterr Health J. 2022;28(9):682–689. doi:10.26719/emhj.22.060
   PubMed Web of Science ®Google Scholar
• Caren GJ, Iskandar D, Pitaloka DAE, et al. COVID-19 pandemic disruption on the management of tuberculosis treatment in Indonesia. J Multidisciplinary Healthcare. 2022;Volume 15:175–183. doi:10.2147/JMDH.S341130
   Web of Science ®Google Scholar
• Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(9):e1132–e1141. doi:10.1016/S2214-109X(20)30288-6
   PubMed Web of Science ®Google Scholar
• Dhamnetiya D, Patel P, Jha RP, et al. Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age–period–cohort analysis. BMC Pulm Med. 2021;21(1). doi:10.1186/s12890-021-01740-y.
   PubMed Web of Science ®Google Scholar
• Giacomet CL, Santos MS, Berra TZ, et al. Tendência temporal da incidência de tuberculose e sua distribuição espacial em Macapá-AP. Revista de Saúde Pública. 2021;55:55. doi:10.11606/s1518-8787.2021055003218
   PubMedGoogle Scholar
• Wah W, Das S, Earnest A, et al. Time series analysis of demographic and temporal trends of tuberculosis in Singapore. BMC Public Health. 2014;14:1121. doi:10.1186/1471-2458-14-1121
   PubMed Web of Science ®Google Scholar
• Tao -N-N, Y-F L, Wang -S-S, et al. Epidemiological characteristics of pulmonary tuberculosis in Shandong, China, 2005–2017. Medicine. 2019;98(21):e15778. doi:10.1097/MD.0000000000015778
   PubMed Web of Science ®Google Scholar
• Shandong provincial Bureau of Statistics. Shandong Statistical Yearbook; 2005-2021 Available from: http://tjj.shandong.gov.cn/col/col6279/index.html. Accessed October 02, 2023.
   Google Scholar
• World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision: updated December 2014 and January 2020; 2013 Available from: https://www.who.int/publications/i/item/9789241505345. Accessed November 12, 2013.
   Google Scholar
• Liang Z, Ma Z. China’s floating population: new evidence from the 2000 census. Popul Dev Rev. 2004;30(3):467–488. doi:10.1111/j.1728-4457.2004.00024.x
   Web of Science ®Google Scholar
• Wang L, Wang W. Temporal trends in notification and mortality of tuberculosis in china, 2004–2019: a joinpoint and age–period–cohort analysis. Int J Environ Res Public Health. 2021;18(11):5607
   PubMed Web of Science ®Google Scholar
• Yang S, Wu J, Ding C, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis. 2017;17(7):716–725. doi:10.1016/S1473-3099(17)30227-X
   PubMed Web of Science ®Google Scholar
• Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet. 2007;369(9562):691–696. doi:10.1016/S0140-6736(07)60316-X
   PubMed Web of Science ®Google Scholar
• Xianyi C, Fengzeng Z, Hongjin D, et al. The DOTS strategy in China: results and lessons after 10 years. Bullet World Health Organ. 2002;80(6):430–436.
   PubMed Web of Science ®Google Scholar
• State Council of the People’s Republic of China. Law of the People’s Republic of China on the prevention and treatment of infectious diseases;2004 Available from: https://www.gov.cn/gongbao/content/2004/content_62975.htm. Accessed November 18, 2023.
   Google Scholar
• Ma JQ, Yang GH, S XM. Information technology platform in China’s disease surveillance system. Dis Surveill. 2006;2006(01):1–3.
   Google Scholar
• Hong C-Y, Wang F-L, Zhang Y-T, et al. Time-trend analysis of tuberculosis diagnosis in Shenzhen. China Between 2011 and 2020 Front Public Health. 2023;11:1059433
   Google Scholar
• Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. New Engl J Med. 2010;363(11):1005–1015. doi:10.1056/NEJMoa0907847
   PubMed Web of Science ®Google Scholar
• Rasool G, Khan AM, Mohy-Ud-Din R, Riaz M. Detection of mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and genexpert® MTB/RIF assay. Inter j Immuno Pharmacol. 2019;33:2058738419827174
   Google Scholar
• Tostmann A, Kik Sandra V, Kalisvaart Nico A, et al. Tuberculosis transmission by patients with smear‐negative pulmonary tuberculosis in a large cohort in the Netherlands. Clinl Infect Dis. 2008;47(9):1135–1142. doi:10.1086/591974
   PubMed Web of Science ®Google Scholar
• Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar J-W. Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. J Infect. 2018;77(6):469–478. doi:10.1016/j.jinf.2018.10.004
   PubMed Web of Science ®Google Scholar
• Yen Y-F, H-Y H, Lee Y-L, et al. Sexual inequality in incident tuberculosis: a cohort study in Taiwan. BMJ Open. 2018;8(2):e020142. doi:10.1136/bmjopen-2017-020142
   PubMed Web of Science ®Google Scholar
• Zhang C-Y, Zhao F, Xia -Y-Y, et al. Prevalence and risk factors of active pulmonary tuberculosis among elderly people in China: a population based cross-sectional study. Infect Diseases Poverty. 2019;8(1). doi:10.1186/s40249-019-0515-y.
   Web of Science ®Google Scholar
• Jiang H, Liu M, Zhang Y, et al. Changes in incidence and epidemiological characteristics of pulmonary tuberculosis in mainland china, 2005-2016. JAMA Network Open. 2021;4(4):e215302. doi:10.1001/jamanetworkopen.2021.5302
   PubMed Web of Science ®Google Scholar
• Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis. 2015;15(3):310–319. doi:10.1016/S1473-3099(14)71085-0
   PubMed Web of Science ®Google Scholar
• Ria F, Bele S, Jiang W, et al. Population aging and migrant workers: bottlenecks in tuberculosis control in rural China. PLoS One. 2014;9(2).
   Web of Science ®Google Scholar
• D’Agostino P, Milano S, Barbera C, et al. Sex hormones modulate inflammatory mediators produced by macrophages. Ann NY Acad Sci. 1999;876:426–429. doi:10.1111/j.1749-6632.1999.tb07667.x
   PubMed Web of Science ®Google Scholar
• Lin -H-H, Ezzati M, Chang H-Y, Murray M. Association between tobacco smoking and active tuberculosis in Taiwan. Am J Respir Crit Care Med. 2009;180(5):475–480. doi:10.1164/rccm.200904-0549OC
   PubMed Web of Science ®Google Scholar
• Amoakwa K, Martinson NA, Moulton LH, et al. Risk factors for developing active tuberculosis after the treatment of latent tuberculosis in adults infected with human immunodeficiency virus. Open Forum Infect Diseases. 2015;2(1). doi:10.1093/ofid/ofu120.
   PubMed Web of Science ®Google Scholar
• Friedman A, Turner J, Szomolay B. A model on the influence of age on immunity to infection with mycobacterium tuberculosis. Exp Gerontology. 2008;43(4):275–285. doi:10.1016/j.exger.2007.12.004
   PubMed Web of Science ®Google Scholar
• Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Inter J Infect Dis. 2015;32:138–146. doi:10.1016/j.ijid.2014.12.016
   PubMed Web of Science ®Google Scholar
• Shandong Provincial People’s Government. The main data of the 7th national population census of Shandong Province was released; 2021 Available from: http://www.shandong.gov.cn/art/2021/5/22/art_97560_414437.html. Accessed November 22, 2023.
   Google Scholar
• Shah S, Khan A, Shahzad M, et al. Determinants of response at 2 months of treatment in a Cohort of Pakistani patients with pulmonary tuberculosis. Antibiotics. 2022;11(10):1307. doi:10.3390/antibiotics11101307
   Google Scholar
• Volmink J, Garner P, Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2007;4:Cd003343. doi:10.1002/14651858.CD003343.pub3
   PubMed Web of Science ®Google Scholar
• Munro SA, Lewin SA, Smith HJ, et al. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238. doi:10.1371/journal.pmed.0040238
   PubMed Web of Science ®Google Scholar
• Gabdullina M, Maes EF, Horth RZ, et al. COVID-19 pandemic and other factors associated with unfavorable tuberculosis treatment outcomes—Almaty, Kazakhstan, 2018–2021. Front Public Health. 2023;11.
   PubMed Web of Science ®Google Scholar
• World Health Organization. COVID-19: considerations for tuberculosis (TB) care; 2020 Available from: https://www.who.int/docs/default-source/documents/tuberculosis/infonote-tb-covid-19.pdf. Accessed November 30, 2023.
   Google Scholar
• Dheda K, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022;10(6):603–622. doi:10.1016/S2213-2600(22)00092-3
   PubMed Web of Science ®Google Scholar
• Magro P, Formenti B, Marchese V, et al. Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy. Eur Respir J. 2020;56(4):2002665. doi:10.1183/13993003.02665-2020
   PubMed Web of Science ®Google Scholar